Cite
Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial
MLA
Ryan Miller, et al. “Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial.” Advances in Radiation Oncology, vol. 8, no. 2, Oct. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....073a3c53a1b70ec4ad9abe9ca9974b4a&authtype=sso&custid=ns315887.
APA
Ryan Miller, Richard Castillo, Edward Castillo, Bernard L. Jones, Moyed Miften, Brian Kavanagh, Bo Lu, Maria Werner-Wasik, Nader Ghassemi, Joseph Lombardo, Julie Barta, Inga Grills, Chad G. Rusthoven, Thomas Guerrero, & Yevgeniy Vinogradskiy. (2022). Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial. Advances in Radiation Oncology, 8(2).
Chicago
Ryan Miller, Richard Castillo, Edward Castillo, Bernard L. Jones, Moyed Miften, Brian Kavanagh, Bo Lu, et al. 2022. “Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial.” Advances in Radiation Oncology 8 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....073a3c53a1b70ec4ad9abe9ca9974b4a&authtype=sso&custid=ns315887.